A Case Report on Bortezomib-Induced Hypotension: Rare Adverse Effect in Proteasome Inhibitor TherapySeptember 3, 2025Conference CoverageOncologyMultiple MyelomaHematologic MalignanciesImmuno-oncology
An Uncommon Presentation of Marginal Zone Lymphoma Involving the Sciatic ForamenSeptember 2, 2025Conference CoverageOncologyHematologic Malignancies
RVD With Weekly Bortezomib Has a Favorable Toxicity and Effectiveness Profile in a Large Cohort of US Veterans With Multiple MyelomaSeptember 10, 2024OncologyMultiple MyelomaHematologic Malignancies
Chronic Myeloid Leukemia Presenting as Priapism: A Rare and Acute Initial Presentation in a Young MaleSeptember 9, 2024OncologyHematologic Malignancies
The First Female Patient in the Veteran Affairs System to Receive Chimeric Antigen Receptors (CAR) T-cell Therapy for Refractory Multiple Myeloma and the Role of CAR T-cell Therapy in Penta-refractory DiseaseSeptember 9, 2024OncologyMultiple MyelomaHematologic Malignancies
Is Location a Risk Factor for Early-Onset Cancer?June 18, 2024OncologyCancerGenitourinary CancerHematologic Malignancies
Cancer Data Trends 2024March 15, 2024CancerBreast CancerColon and RectalGenitourinary CancerHematologic MalignanciesHepatocellular CarcinomaLung Cancer
How Does Military Service Impact Cancer Risk? It’s ComplicatedOctober 25, 2023OncologyHematologic Malignancies
Metastatic Urothelial Carcinoma Presenting as Mediastinal Lymphadenopathy Without Appreciable Bladder Mass in a Patient With Chronic Lymphocytic LeukemiaSeptember 14, 2023Genitourinary CancerHematologic MalignanciesCancerOncology
FDA approves motixafortide for stem cell mobilization in myelomaSeptember 11, 2023Multiple MyelomaHematologic Malignancies
Chimeric Antigen Receptor T-Cell Therapy in the Veterans Affairs Network: the Tennessee Valley Healthcare System ExperienceSeptember 10, 2023Hematologic MalignanciesOncology
Does Gemcitabine Have a Curative Role in Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia?September 10, 2023Hematologic Malignancies
Asciminib Chronic Phase Chronic Myeloid Leukemia: A Real-World Single Institution Case SeriesSeptember 10, 2023Hematologic MalignanciesOncology
